Log in

Relevant bibliographies by topics / Venous Stent / Journal articles

To see the other types of publications on this topic, follow the link: Venous Stent.

Journal articles on the topic 'Venous Stent'

Author: Grafiati

Published: 7 June 2025

Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Venous Stent.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Huda, Syed Arqum, Sara Akram Kahlown, Anojan Pathmanathan, Muhammad Saad Farooqi, and Mark Charlamb. "Stent Embolization Mimicking Acute Myocardial Infarction." Journal of Investigative Medicine High Impact Case Reports 9 (January 2021): 232470962110365. http://dx.doi.org/10.1177/23247096211036537.

Full text

Abstract:

Venous thromboembolism is associated with significant morbidity and mortality if left untreated. Anticoagulation is the cornerstone of treatment. Venous stents are a relatively newer entity that are increasingly being used to treat venous stenosis/occlusion. It is a safe procedure, but complications include vein rupture, arterial puncture, retroperitoneal bleeding, and in-stent thrombosis. Stent migration is a rare but potentially fatal complication. We present a case of venous stent embolization to the heart that presented as a non-ST segment elevation myocardial infarction.

APA, Harvard, Vancouver, ISO, and other styles

2

Robertson, Cameron, Ramon L. Varcoe, Stephen Black, and Shannon D. Thomas. "Histopathology of Iliocaval Venous In-Stent Restenosis Treated With Directional Atherectomy." Journal of Endovascular Therapy 26, no. 5 (2019): 742–46. http://dx.doi.org/10.1177/1526602819857240.

Full text

Abstract:

Purpose: To report the use of directional atherectomy to treat venous in-stent restenosis (ISR) and subsequent histopathological analysis of retrieved intrastent tissue. Case Report: A 55-year-old man presented with recurrent symptoms of venous congestion following iliofemoral stenting. The stents were found to be occluded on imaging. Directional atherectomy was used to recanalize the iliofemoral venous stents, which provided significant symptom relief. Tissue retrieved from within the stent demonstrated patterns of cellular components similar to arterial ISR. At 6-month follow-up, the stents

APA, Harvard, Vancouver, ISO, and other styles

3

Kothwala, Dr. Deveshkumar Patel Hemant Bhatvedekar Neha*. "Advancing Venous Interventions: In-Vitro Evaluation of a Novel Self-Expanding Venous Stent System." International Journal of Scientific Research and Technology 2, no. 5 (2025): 169–76. https://doi.org/10.5281/zenodo.15345974.

Full text

Abstract:

<strong>Background</strong>: Venoplasty and venous stenting are commonly used to treat chronically thrombosed veins. However, venous angioplasty alone is often insufficient due to low intravascular pressure in the venous system, necessitating the use of metal stents for long-term patency. Venous outflow obstruction can lead to chronic venous insufficiency, pain, and mobility impairment, requiring precise medical intervention. The Self-Expanding Venous Stent System is an endovascular device designed to maintain vessel patency by providing structural support. It consists of a hybrid closed-cell

APA, Harvard, Vancouver, ISO, and other styles

4

Shintaku, Sadanori, Tomoyasu Sato, Hideki Kawanishi, Misaki Moriishi, and Shinichiro Tsuchiya. "The efficacy of drug-eluting stent for recurrent central venous restenosis in a patient undergoing hemodialysis." Journal of Vascular Access 20, no. 1_suppl (2018): 76–79. http://dx.doi.org/10.1177/1129729818763473.

Full text

Abstract:

Introduction: Recurrent central venous restenosis is problematic in patients with ipsilateral arteriovenous fistula. We report our experience using a drug-eluting stent for the treatment of recurrent central vein restenosis. Case report: A 60-year-old man consulted our hospital because of recurrent swelling of his left upper limb with radial-cephalic arteriovenous fistula that originated in the distal forearm. More than 3 years prior, two bare-metal stents were placed for the obstructed lesions in the left subclavian and brachiocephalic venous lesions, and repeated balloon angioplasty for recu

APA, Harvard, Vancouver, ISO, and other styles

5

Breen, Karen, Prakash Saha, Narayan Karanunithy, et al. "Outcomes Following Placement of Venous Stents for Treatment of Thrombotic Venous Disease." Blood 130, Suppl_1 (2017): 697. http://dx.doi.org/10.1182/blood.v130.suppl_1.697.697.

Full text

Abstract:

Abstract Background Endovenous stenting is a method to overcome venous outflow obstruction in the treatment of patients with acute iliofemoral deep vein thrombosis (DVT) or in those with symptomatic post-thrombotic syndrome (PTS). These treatments allow maximal luminal expansion of the caval and/or iliac venous segment leading to a reduction in venous hypertension. While there is growing enthusiasm for their use, particularly as conventional treatments usually with anticoagulation are not always effective there is however little clinical data regarding efficacy in improving clinical outcome. O

APA, Harvard, Vancouver, ISO, and other styles

6

Lin, Chenyu, Karlyn A. Martin, Mei Wang, Brady L. Stein, and Kush R. Desai. "Long-term antithrombotic therapy after venous stent placement." Phlebology: The Journal of Venous Disease 35, no. 6 (2019): 402–8. http://dx.doi.org/10.1177/0268355519893819.

Full text

Abstract:

Objectives To examine the prescribing patterns and outcomes of antithrombotic regimens after venous stent placement. Methods A total of 87 patients who received inferior vena cava or iliofemoral venous stents were included in the study. A retrospective review was performed to determine the antithrombotic regimens and the subsequent rates of in-stent restenosis, stent thrombosis, and bleeding. Results The prescribing patterns of specific antithrombotic regimens were highly variable. In-stent restenosis and stent thrombosis events were observed in 13 of 63 patients (21%) with available follow-up

APA, Harvard, Vancouver, ISO, and other styles

7

Barbati, Mohammad E., Alexander Gombert, Irwin Toonder, et al. "Detecting stent geometry changes after venous recanalization using duplex ultrasound." Phlebology: The Journal of Venous Disease 34, no. 1 (2018): 8–16. http://dx.doi.org/10.1177/0268355518757240.

Full text

Abstract:

Background Patients with post-thrombotic syndrome due to chronic venous obstruction and resistant to conservative management can benefit from endovenous revascularization. The current study investigated the usefulness of duplex ultrasound in monitoring the stent changes over the time. Method All duplex ultrasound images of treated patients were reviewed retrospectively. The stent diameter and area during the follow-up visits have been analyzed. Result A total of 210 stents were placed in 137 limbs. Duplex ultrasound findings showed a decrease in area of stent in all patients (mean: 0.69 cm2).

APA, Harvard, Vancouver, ISO, and other styles

8

Alqahtani, Saad Saeed, Ahmed Kandeel Elhadad, Rusha Abdulmohsen Sarhan, and Saleh Mohamed Alwaleedi. "Endovascular retrieval of two migrated stents from pulmonary artery by means of balloon catheter." American Journal of Interventional Radiology 5 (November 24, 2021): 21. http://dx.doi.org/10.25259/ajir_28_2021.

Full text

Abstract:

Long-term central venous catheters can be associated with central venous stenosis in up to 50% of cases. Central venous stenosis can be managed with central venous stenting which was demonstrated to restore patency and improve suboptimal results after percutaneous transluminal angioplasty. Dislodgment of venous stents into the right side of the heart or the pulmonary artery during stent deployment is one of the most feared complications of this procedure. Percutaneous removal of these migrated stents is the preferred alternative for the more invasive operative intervention, which may be very h

APA, Harvard, Vancouver, ISO, and other styles

9

Jalaie, H., CWKP Arnoldussen, ME Barbati, et al. "What predicts outcome after recanalization of chronic venous obstruction: hemodynamic factors, stent geometry, patient selection, anticoagulation or other factors?" Phlebology: The Journal of Venous Disease 29, no. 1_suppl (2014): 97–103. http://dx.doi.org/10.1177/0268355514529510.

Full text

Abstract:

In this review we evaluated the effect of different suggested factors associate with the outcome after recanalization of chronic venous obstruction (CVO). Hemodynamic factors: Based upon literature no clear suggestions can be made to identify the risk of stent occlusion in association with the hemodynamic effects. However it is evident that ensuring optimal in- and outflow of the stented tract is key in maintaining the patency. Patient selection: Noninvasive imaging modalities are used to divide patients in three subgroups based on the place and extension of post-thrombotic changes. Moreover i

APA, Harvard, Vancouver, ISO, and other styles

10

Kumpe, David A., Jeffrey L. Bennett, Joshua Seinfeld, Victoria S. Pelak, Ashish Chawla, and Mary Tierney. "Dural sinus stent placement for idiopathic intracranial hypertension." Journal of Neurosurgery 116, no. 3 (2012): 538–48. http://dx.doi.org/10.3171/2011.10.jns101410.

Full text

Abstract:

Object The use of unilateral dural sinus stent placement in patients with idiopathic intracranial hypertension (IIH) has been described by multiple investigators. To date there is a paucity of information on the angiographic and hemodynamic outcome of these procedures. The object of this study was to define the clinical, angiographic, and hemodynamic outcome of placement of unilateral dural sinus stents to treat intracranial venous hypertension in a subgroup of patients meeting the diagnostic criteria for IIH. Methods Eighteen consecutive patients with a clinical diagnosis of IIH were treated

APA, Harvard, Vancouver, ISO, and other styles

11

Lichtenberg, Michael, Frank Breuckmann, Wilhelm Friedrich Stahlhoff, Peter Neglén, and Rick de Graaf. "Placement of closed-cell designed venous stents in a mixed cohort of patients with chronic venous outflow obstructions – short-term safety, patency, and clinical outcomes." Vasa 47, no. 6 (2018): 475–81. http://dx.doi.org/10.1024/0301-1526/a000731.

Full text

Abstract:

Abstract. Background: To evaluate the performance of a closed-cell designed venous stent for the treatment of chronic ilio-femoral venous outflow obstruction (VOO) in the shortterm. Patients and methods: Safety, stent patency and clinical outcome after placement of the Vici Venous Stent® in patients with chronic ilio-femoral venous obstruction were assessed retrospectively. Stent patency was evaluated by duplex ultrasound scanning, and clinical outcome was determined using the revised Venous Clinical Severity score (rVCSS). Results: 75 patients (49 % female; median age 57 years; 82 limbs) with

APA, Harvard, Vancouver, ISO, and other styles

12

Lugli, M., and O. Maleti. "Preliminary report on a new concept stent prototype designed for venous implant." Phlebology: The Journal of Venous Disease 30, no. 7 (2014): 462–68. http://dx.doi.org/10.1177/0268355514539680.

Full text

Abstract:

Venous obstruction at iliocaval level in both forms, primary and secondary, is a significant cause of severe chronic venous insufficiency. A new therapeutic approach to this pathology emerged with the introduction of stenting procedures that proved effective, leading to good long-term results. However, at present, the majority of implanted stents have been designed for arterial implant and this can pose a limit in particular districts. The purpose of this preliminary acute study was to verify the deliverability and safety of a new stent specially designed for venous-vessel implant. We assess t

APA, Harvard, Vancouver, ISO, and other styles

13

Khalid, Mazin O., Norbert Moskovits, Robert A. Frankel, et al. "Venous Stent Migrating to the Right Heart Causing Severe Regurgitation." Journal of Investigative Medicine High Impact Case Reports 8 (January 2020): 232470962097422. http://dx.doi.org/10.1177/2324709620974220.

Full text

Abstract:

Venous stent migration to the cardiopulmonary system is a rare but serious complication. Cardiopulmonary involvement has various presentations such as valvulopathy, acute heart failure, arrhythmias, endocarditis, and tamponade. The presenting symptoms depend on the eventual location of the stent in the heart or lungs, size of the stent, and valve involvement. Extracardiac dislodgement can be managed by catheter-directed extraction or proper deployment within the containing vessel or surgical extraction. Intracardiac stents may require open surgery to prevent life-threatening complications. We

APA, Harvard, Vancouver, ISO, and other styles

14

Che, Haijie, Jingjun Jiang, Hao Liu, Jichang Wei, and Xiaoming Zhang. "Preliminary report of a new type of braided vein stent in animals." Phlebology: The Journal of Venous Disease 34, no. 4 (2018): 246–56. http://dx.doi.org/10.1177/0268355518801172.

Full text

Abstract:

Background Iliofemoral vein stenosis or occlusion is a common cause of severe chronic venous insufficiency. Endovascular venous stenting has become a preferred treatment because it is minimally invasive and has a high safety profile. Despite the wide application of the wallstent, it is not specifically designed for veins. There are currently few studies on braided stents in the field of veins. We designed a novel braided vein stent, which has higher radial resistive force and more optimized looped ends structure compared with the wallstent. The purpose of this study was to evaluate the safety

APA, Harvard, Vancouver, ISO, and other styles

15

Dikmen, Nur, Evren Ozcinar, Ali Ihsan Hasde, et al. "Stent-Induced Inflammation: A Comparative Cross-Sectional Study of Post-Implantation Syndrome in Venous and Arterial Procedures." Journal of Clinical Medicine 13, no. 19 (2024): 5937. http://dx.doi.org/10.3390/jcm13195937.

Full text

Abstract:

Background: Postimplantation syndrome (PIS) is a known inflammatory response following endovascular stent placement, yet comparative data between venous and arterial stenting remains limited. This study seeks to evaluate the incidence, characteristics, and clinical implications of PIS across these two distinct vascular territories. Methods: We retrospectively analyzed 191 patients who underwent either venous (n = 36) or arterial (n = 155) stent placement. Data collection encompassed demographic profiles, perioperative laboratory findings, and clinical outcomes. The primary endpoint was the inc

APA, Harvard, Vancouver, ISO, and other styles

16

Marino, Angelo G., and Alfred Lee. "Maintained patency and symptom resolution after treatment of recurrent in-stent thrombosis with novel RevCore thrombectomy system: A case report." American Journal of Interventional Radiology 8 (June 29, 2024): 6. http://dx.doi.org/10.25259/ajir_8_2024.

Full text

Abstract:

In-stent thrombosis (IST) is a frequent complication following intervention to remove thrombus and treat residual venous outflow obstruction or stenosis. Treatment is often limited to venoplasty and stent relining, which only temporarily restores stent patency until rethrombosis inevitably occurs. As a result, disease management becomes a cycle of repeated recanalization procedures without long-term relief. This report highlights an early use case of a novel device capable of debulking material in the peripheral vasculature and restoring patency to occluded stents. A 60-year-old male with a 25

APA, Harvard, Vancouver, ISO, and other styles

17

Meissner, M. H. "Indications for platelet aggregation inhibitors after venous stents." Phlebology: The Journal of Venous Disease 28, no. 1_suppl (2013): 91–98. http://dx.doi.org/10.1177/0268355513476828.

Full text

Abstract:

Iliofemoral venous obstruction may arise from either primary compressive lesions or may be secondary to an episode of deep venous thrombosis. Regardless of aetiology, these lesions, either alone or in association with more distal reflux, may be responsible for lower extremity pain, swelling, and ulceration. Conventional surgical procedures for the treatment of iliofemoral venous obstruction have largely been supplanted by endovascular approaches relying on the deployment of venous stents. Large series have reported good technical and clinical results from venous stenting, particularly for prim

APA, Harvard, Vancouver, ISO, and other styles

18

Ramot, Yuval, Michal Steiner, Udi Vazana, Abraham Nyska, and Anat Horev. "VIVA Stent Preclinical Evaluation in Swine: A Novel Cerebral Venous Stent with a Unique Delivery System." Journal of Clinical Medicine 14, no. 13 (2025): 4721. https://doi.org/10.3390/jcm14134721.

Full text

Abstract:

Background: Venous sinus stenting is a promising treatment for intracranial venous disorders, such as idiopathic intracranial hypertension and pulsatile tinnitus, associated with transverse sinus stenosis. The VIVA Stent System (VSS) is a novel self-expanding braided venous stent designed to navigate tortuous cerebral venous anatomy. This preclinical study assessed the safety, thrombogenicity, and performance of the VSS in a swine model. Methods: Fifteen swine underwent bilateral internal mammary vein stenting with either the VSS (n = 9) or the PRECISE® PRO RX stent (n = 6, reference). Fluoros

APA, Harvard, Vancouver, ISO, and other styles

19

Horita, Yuki. "Percutaneous transluminal angioplasty for central venous stenosis or occlusion in hemodialysis patients." Journal of Vascular Access 20, no. 1_suppl (2018): 87–92. http://dx.doi.org/10.1177/1129729817747545.

Full text

Abstract:

The objectives of central venous percutaneous transluminal angioplasty are to dilate the venous lesion and to extend the life of arteriovenous fistula for hemodialysis. It is reasonable to perform percutaneous transluminal angioplasty for central venous lesions if this interventional therapy is required to maintain stable dialysis therapy. However, the presence of large fresh thrombus at central venous lesion site represents a contraindication to percutaneous transluminal angioplasty unless the thrombus can first be removed by thrombectomy. Balloon angioplasty is a basic treatment for central

APA, Harvard, Vancouver, ISO, and other styles

20

Farrington, Crystal A., Ahmed K. Abdel-Aal, and Ammar Almehmi. "Novel treatment of a totally occluded venous outflow tract of an arteriovenous graft." Journal of Vascular Access 20, no. 3 (2018): 333–36. http://dx.doi.org/10.1177/1129729818795131.

Full text

Abstract:

Introduction: Conventional guidewire techniques are not always sufficient to restore arteriovenous graft patency in patients with challenging vascular scenarios. We discuss a novel approach to the treatment of chronic total occlusion of the venous outflow tract to enable successful arteriovenous graft thrombectomy. Case presentation: A 28-year-old female with end-stage renal disease on chronic hemodialysis and recurrent arteriovenous graft thromboses presented with a clotted thigh graft. An existing ipsilateral common femoral vein stent was found to be chronically occluded, causing persistent

APA, Harvard, Vancouver, ISO, and other styles

21

Gabelmann, Andreas, Stefan C. Krämer, Reinhard Tomczak, and Johannes Görich. "Percutaneous Techniques for Managing Maldeployed or Migrated Stents." Journal of Endovascular Therapy 8, no. 3 (2001): 291–302. http://dx.doi.org/10.1177/152660280100800309.

Full text

Abstract:

Purpose: To report our experience in the percutaneous management of dislocated endovascular stents. Methods: During a 6-year period, 28 (2.7%) patients with a maldeployed or migrated endovascular stent (20 Palmaz, 5 Wallstent, 2 Memotherm, and 1 AVE) were recognized among 1021 patients undergoing noncardiac vascular stent procedures. Percutaneous stent management was performed using balloon catheters, gooseneck snares, grasping forceps, or additional stent implantation on the basis of the stent type, degree of expansion, mechanical characteristics, and location of the stent. Results: Three ste

APA, Harvard, Vancouver, ISO, and other styles

22

Raper, Daniel M. S., Dale Ding, Ching-Jen Chen, Thomas J. Buell, R. Webster Crowley, and Kenneth C. Liu. "Patency of the vein of Labbé after venous stenting of the transverse and sigmoid sinuses." Journal of NeuroInterventional Surgery 9, no. 6 (2017): 587–90. http://dx.doi.org/10.1136/neurintsurg-2016-012903.

Full text

Abstract:

BackgroundVenous sinus stenting is an emerging treatment for patients with idiopathic intracranial hypertension and evidence of venous stenosis. Stents placed across the transverse and sigmoid sinuses often cover the vein of Labbé (VOL), a major anastomotic vein draining the cerebral hemisphere. The patency of the VOL after stenting and its clinical implications are poorly understood.MethodsA retrospective analysis was performed of a prospectively collected database of patients undergoing venous sinus stenting. Pre- and post-stent angiography were compared to assess changes in VOL patency, cli

APA, Harvard, Vancouver, ISO, and other styles

23

Ronald, James, Bradley Davis, Carlos J. Guevara, Waleska M. Pabon-Ramos, Tony P. Smith, and Charles Y. Kim. "Treatment of central venous in-stent restenosis with repeat stent deployment in hemodialysis patients." Journal of Vascular Access 18, no. 3 (2017): 214–19. http://dx.doi.org/10.5301/jva.5000705.

Full text

Abstract:

Purpose To report patency rates for stent deployment for treatment of in-stent stenosis of the central veins of the chest in hemodialysis patients. Materials and Methods A retrospective analysis was performed on 29 patients who underwent 35 secondary percutaneous transluminal stent (PTS) deployments for in-stent stenosis within the central veins that were refractory to angioplasty and ipsilateral to a functioning hemodialysis access (in-stent PTS group). For comparison, patency data were acquired for 47 patients who underwent 78 successful percutaneous transluminal angioplasty (PTA) procedures

APA, Harvard, Vancouver, ISO, and other styles

24

Abreo, Kenneth, and Adrian Sequeira. "Role of stents in hemodialysis vascular access." Journal of Vascular Access 19, no. 4 (2018): 341–45. http://dx.doi.org/10.1177/1129729818761280.

Full text

Abstract:

Stents are ubiquitously utilized in coronary and peripheral arterial disease. Interventional nephrologists, however, place stents in the venous outflow of the arteriovenous access. Stenosis is the predominant pathology that causes access dysfunction and will ultimately lead to thrombosis if uncorrected. Angioplasty and stent deployment are the current techniques available to combat stenosis. From initial bare metal stainless steel stents, the current generations of stents used are predominately covered nitinol stents. The latest randomized control trials reveal that stents decrease the number

APA, Harvard, Vancouver, ISO, and other styles

25

Salsano, Giancarlo, Matteo Trezzi, Matteo Barattini, et al. "Viabahn stent for hemodialysis shunt: efficacy, long segment recanalization and prognostic factors for reintervention." Journal of Vascular Access 19, no. 1 (2018): 76–83. http://dx.doi.org/10.5301/jva.5000823.

Full text

Abstract:

Introduction: The study evaluated the Heparin Bioactive Surface (HBS) Viabahn Stent (W.L. Gore & Associates, Flagstaff, Arizona) efficacy in the maintenance or re-establishment of hemodialysis. Materials and methods: Fifty HBS Viabahn stents deployed in 37 consecutive patients with hemodialysis dysfunction from January 2008 to May 2016 were evaluated in a single-institution retrospective review. Outcomes were stent patency intended as primary circuit patency (PP), assisted primary patency (APP), target lesion primary patency (TLPP) and secondary patency (SP). Moreover, the risk factor anal

APA, Harvard, Vancouver, ISO, and other styles

26

Chen, Adrian, Sabrina Begley, and Timothy G. White. "NCMP-18. ENDOVASCULAR TREATMENT OF SYMPTOMATIC TUMORAL VENOUS SINUS STENOSIS: COMPARATIVE ANALYSIS OF CORONARY BALLOON-MOUNTED STENTS AND CONVENTIONAL TECHNIQUES." Neuro-Oncology 25, Supplement_5 (2023): v210—v211. http://dx.doi.org/10.1093/neuonc/noad179.0802.

Full text

Abstract:

Abstract Meningiomas may lead to symptomatic papilledema due to elevated intracranial pressure (ICP) from venous sinus compression. While venous sinus stenting has proven effective for treating elevated intracranial pressure, evidence for its application in tumoral-induced stenosis and acquired intracranial hypertension is limited. This study presents an institutional series of symptomatic tumoral venous sinus stenosis cases and compares the technical considerations of endovascular treatment using a coronary balloon-mounted stent to conventional venous sinus stenting. Three patients with menin

APA, Harvard, Vancouver, ISO, and other styles

27

Young, Christopher C., Ryan P. Morton, Basavaraj V. Ghodke, and Michael R. Levitt. "Retrograde 3D rotational venography (3DRV) for venous sinus stent placement in idiopathic intracranial hypertension." Journal of NeuroInterventional Surgery 10, no. 8 (2017): 777–79. http://dx.doi.org/10.1136/neurintsurg-2017-013533.

Full text

Abstract:

BackgroundDural venous sinus stenting has emerged as an effective and durable treatment for idiopathic intracranial hypertension (IIH). Improved visualization of the venous sinuses can improve stent placement.MethodsWe present two cases of IIH treated with venous sinus stenting in which retrograde three-dimensional rotational venography (3DRV) provided superior anatomical details of the venous sinuses for optimal sizing and positioning of stent.ResultsComparison of pre-stent 3DRV with post-stent contrast-enhanced flat panel detector CT allowed confirmation of stent placement and the result of

APA, Harvard, Vancouver, ISO, and other styles

28

Tran, Maxwell A., Priya Lakhanpal, Sanjiv Lakhanpal, Vinay K. Satwah, Gaurav Lakhanpal, and Peter J. Pappas. "Type of anti-thrombotic therapy for venous stenting in patients with non-thrombotic iliac vein lesions does not influence the development of in-stent restenosis." Phlebology: The Journal of Venous Disease 35, no. 10 (2020): 805–13. http://dx.doi.org/10.1177/0268355520941385.

Full text

Abstract:

Background In patients receiving stents for symptomatic non-thrombotic iliac vein lesions, many clinicians prescribe anti-thrombotic medications. Whether or not anti-coagulation post-venous stenting improves stent patency is unknown. The aim of this investigation is to determine whether prophylactic post-operative anti-thrombotic therapy improves stent patency and/or prevents in-stent restenosis. Methods The medical records and venous ultrasounds for 389 patients stented for non-thrombotic iliac vein lesions were retrospectively reviewed. Patients were categorized into three anti-thrombotic re

APA, Harvard, Vancouver, ISO, and other styles

29

De Graaf, R., and C. H. A. Wittens. "Endovascular Treatment Options for Chronic Venous Obstructions." Phlebology: The Journal of Venous Disease 27, no. 1_suppl (2012): 171–77. http://dx.doi.org/10.1258/phleb.2012.012s13.

Full text

Abstract:

Chronic venous obstructions have been treated by means of bypass surgery, until, in recent decades, it was surpassed by endovascular treatment options. Although techniques may differ, some issues should be universal. It is recommended that patients are treated under general anaesthesia. Secondly, obstructive lesions should be fully stented. Finally, self-expandable stents should mainly be used. Recanalization and stenting proved safe and efficient with excellent mid- and long-term patency rates. However, failures due to re-occlusion do occur and are basically related to imperfect stent design

APA, Harvard, Vancouver, ISO, and other styles

30

Minocha, Pramodkumar, Deveshkumar Kothwala, Khusboo Shah, et al. "Evaluating the Safety and Efficacy of Developed Self-Expanding Venous Stent System in a Porcine Model." International Journal of Pharmaceutical and Clinical Research 16, no. 10 (2024): 1100–1117. https://doi.org/10.5281/zenodo.14065588.

Full text

Abstract:

The study evaluated the safety and performance of the self-expanding venous stent system in a porcine model. The research was conducted following the guidelines of Cardiovascular Implants—Endovascular devices-: Vascular stents (ISO 25539:2020). The study involved three female pigs that were fasted overnight without water access. All animals passed the physical examination criteria without major clinical observations or weight loss. Procedures were performed on days 0, 30, 90, and 180 under proper analgesia and anesthesia. The stented veins were harvested for histopathological evaluation

APA, Harvard, Vancouver, ISO, and other styles

31

Lichtenberg, Michael K. W., Wilhelm F. Stahlhoff, Stefan Stahlhoff, Ahmet Özkapi, Frank Breuckmann, and Rick de Graaf. "Venovo venous stent for treatment of non-thrombotic or post-thrombotic iliac vein lesions – long-term efficacy and safety results from the Arnsberg venous registry." Vasa 50, no. 1 (2021): 52–58. http://dx.doi.org/10.1024/0301-1526/a000893.

Full text

Abstract:

Summary: Background: Endovascular venous stenting with dedicated venous stents for the treatment of chronic venous outflow obstruction is developing as efficacious alternative to conservative therapy or open surgery. However, so far, mid- and long-term evidence on effectiveness and safety is poor. Patients and methods: The prospective, single-center, observational study enrolled consecutive patients with chronic non-thrombotic iliac vein lesions (NIVL) or post-thrombotic iliofemoral obstructions (PTO). From February 2016 to April 2017, patients underwent implantation of open cell, self-expanda

APA, Harvard, Vancouver, ISO, and other styles

32

Dutmers, Jennifer, Erik Soule, Mario Agrait Bertran, Sonia Andreou, and Jerry Matteo. "Side-by-Side Stenting Repair of a Traumatic Pseudoaneurysm at a Venous Confluence." Vascular and Endovascular Surgery 54, no. 5 (2020): 406–12. http://dx.doi.org/10.1177/1538574420921014.

Full text

Abstract:

Objectives: The incidence and prevalence of iatrogenic vascular trauma in the United States is staggering. This has led to the advent and implementation of more efficient and effective vascular repair methods. Although open surgical repair may still be considered gold standard, new endovascular solutions have emerged as other viable options. When using an endovascular approach, proper stent sizing is vital to a successful repair. Methods: We present a case of a traumatic injury and pseudoaneurysm formation at the confluence of the right internal jugular and right subclavian veins during a cent

APA, Harvard, Vancouver, ISO, and other styles

33

Sebastian, Tim, Michael Lichtenberg, Oliver Schlager, et al. "Early clinical outcomes for treatment of post-thrombotic syndrome and common iliac vein compression with a hybrid Oblique self-expanding nitinol stent – the TOPOS study." Vasa 49, no. 4 (2020): 301–8. http://dx.doi.org/10.1024/0301-1526/a000857.

Full text

Abstract:

Summary: Background: Physical attributes of conventional stents used in the ilio-caval territory are often unfavorable in the presence of external compression close to the bifurcation. A hybrid oblique stent was developed for the treatment of common iliac vein compression without compromising the contralateral iliac vein inflow. Patients and methods: The ongoing international monitored TOPOS study enrolled 60 patients with post-thrombotic syndrome (PTS) treated with the sinus-Obliquus stent (optimed) and provisional distal stent extension. At 3-month follow-up, patency rates were obtained from

APA, Harvard, Vancouver, ISO, and other styles

34

Lumsden, A. B., M. J. MacDonald, H. Isiklar, et al. "Central Venous Stenosis in the Hemodialysis Patient: Incidence and Efficacy of Endovascular Treatment." Cardiovascular Surgery 5, no. 5 (1997): 504–9. http://dx.doi.org/10.1177/096721099700500514.

Full text

Abstract:

Central venous stenosis occurs as a complication of central venous catheterization and significantly complicates delivery of dialysis through arteriovenous grafts in the ipsilateral upper limb. This report includes two separate studies. Functioning expanded polytetrafluorethylene grafts have been prospectively evaluated using duplex scanning and angiography performed in all patients with stenoses >50%. From this, it has been prospectively established that the incidence of unsuspected central venous stenoses in patients with functioning grafts is 29%. In the second part of the report, the au

APA, Harvard, Vancouver, ISO, and other styles

35

Wu, Bei, Guowen Yin, Xu He, et al. "Endovascular Treatment of Cancer-Associated Venous Obstruction: Comparison of Efficacy Between Stent Alone and Stent Combined With Linear Radioactive Seeds Strand." Vascular and Endovascular Surgery 54, no. 7 (2020): 565–72. http://dx.doi.org/10.1177/1538574420939747.

Full text

Abstract:

Objectives: To investigate the safety and efficacy of a stent combined with a linear strand of 125I seeds to treat malignant cancer–associated venous obstruction. Methods: We retrospectively analyzed the data of 57 patients with malignant cancer–associated venous obstruction. Nineteen patients underwent the placement of a stent combined with a linear strand of 125I seeds (group A), and 38 patients underwent the placement of a bare stent (group B). The following parameters were compared between the 2 groups of patients: symptom relief rate, duration of venous patency, survival time, quality of

APA, Harvard, Vancouver, ISO, and other styles

36

Waki, Kenji, Yoshio Arakaki, and Kiyoshi Baba. "Successful release of recurrent pulmonary venous obstruction after repair of totally anomalous pulmonary venous connection by transcatheter implantation of stents." Cardiology in the Young 16, no. 5 (2006): 507–9. http://dx.doi.org/10.1017/s1047951106001028.

Full text

Abstract:

We report a 3-month-old female infant, in whom pulmonary venous obstruction occurred after repair of totally anomalous pulmonary venous connection, and which was successfully released by a transcatheter implantation of a stent using the transseptal approach. Close follow-up is required, since the long-term outcome is still unclear. Nevertheless, transcatheter implantation of stents is a promising option for treating this challenging lesion.

APA, Harvard, Vancouver, ISO, and other styles

37

Asif, H., C. Craven, L. Thorne, L. Watkins, and A. Toma. "TM3-5 Venous sinus stenting for IIH: what are the long-term outcomes?" Journal of Neurology, Neurosurgery & Psychiatry 90, no. 3 (2019): e16.2-e16. http://dx.doi.org/10.1136/jnnp-2019-abn.51.

Full text

Abstract:

ObjectivesIdiopathic intracranial hypertension (IIH) is associated with dural venous sinus stenosis (DVSS). This is increasingly treated with endovascular insertion of stents. Clinical and manometric improvements after stent placement have been described. However, there is little data reporting further need for CSF diversion, complication rates and sustained improvements in ICP.DesignSingle centre case series.SubjectsTwenty-four IIH patients underwent stent insertion on discovery of DVSS with medical management ongoing.MethodsClinical notes, radiographic reports and 24 hour ICP monitoring data

APA, Harvard, Vancouver, ISO, and other styles

38

Lazzaro, Marc A., Ziad Darkhabani, Bernd F. Remler, et al. "Venous Sinus Pulsatility and the Potential Role of Dural Incompetence in Idiopathic Intracranial Hypertension." Neurosurgery 71, no. 4 (2012): 877–84. http://dx.doi.org/10.1227/neu.0b013e318267a8f9.

Full text

Abstract:

Abstract BACKGROUND: Idiopathic intracranial hypertension (IIH) remains a poorly understood and therapeutically challenging disease. Enthusiasm has emerged for endovascular therapy with stent reconstruction of dural sinus narrowing; however, a complete understanding of the hydrodynamic dysequilibrium is lacking. OBJECTIVE: To review and characterize catheter manometry findings including pulsatility changes within the venous sinuses in IIH. METHODS: Cases of venous sinus stent implantation for IIH were retrospectively reviewed. RESULTS: Three cases of venous sinus stent implantation for treatme

APA, Harvard, Vancouver, ISO, and other styles

39

Lin, Chenyu, Karlyn A. Martin, Mei Wang, Brady L. Stein, and Kush R. Desai. "Long-Term Antithrombotic Therapy after Venous Stent Placement." Blood 132, Supplement 1 (2018): 1249. http://dx.doi.org/10.1182/blood-2018-99-111069.

Full text

Abstract:

Abstract Introduction Chronic deep venous insufficiency (CVI) is a common disorder of the venous valves which can cause many debilitating symptoms including edema, pain, and skin changes. CVI may result from a primary non-thrombotic cause, such as May-Thurner syndrome (MTS) or extrinsic compression from a pelvic mass, or as the sequelae of an acute deep vein thrombosis (DVT). Endovascular interventions, including percutaneous transluminal angioplasty and venous stent placement, have been increasingly utilized as a minimally-invasive treatment option for CVI. In patients treated via endovascula

APA, Harvard, Vancouver, ISO, and other styles

40

Holst, Torulv, Thorsten Großwendt, Majd Laham, Mehdy Roosta-Azad, Afsaneh Zandi, and Markus Kamler. "Acute Stent Migration into the Right Ventricle in a Patient with Iliac Vein Stenting." Thoracic and Cardiovascular Surgeon Reports 07, no. 01 (2018): e7-e8. http://dx.doi.org/10.1055/s-0038-1629898.

Full text

Abstract:

AbstractEndovascular stent placement for chronic postthrombotic iliofemoral venous obstructive lesions is an effective therapeutic option and might be complicated by stent migration. We report a case of a venous stent that was lost from the iliac vein into the right ventricle rescued by emergent open-heart surgery.

APA, Harvard, Vancouver, ISO, and other styles

41

Pappas, Peter, Sanjiv Lakhanpal, Levan Sulakvelidze, Maxwell Tran, Arjun Shetty, and Rick Kennedy. "Anticoagulation of Venous Stents for Nonthrombotic Venous Lesions Does Not Increase Stent Patency." Journal of Vascular Surgery: Venous and Lymphatic Disorders 9, no. 2 (2021): 545–46. http://dx.doi.org/10.1016/j.jvsv.2020.12.031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Bækgaard, N., R. Broholm, and S. Just. "Indications for stenting during thrombolysis." Phlebology: The Journal of Venous Disease 28, no. 1_suppl (2013): 112–16. http://dx.doi.org/10.1177/0268355513476818.

Full text

Abstract:

The most important vein segment to thrombolyse after deep venous thrombosis (DVT) is the outflow tract meaning the iliofemoral vein. Iliofemoral DVT is defined as DVT in the iliac vein and the common femoral vein. Spontaneous recanalization is less than 50%, particularly on the left side. The compression from adjacent structures, predominantly on the left side is known as the iliac vein compression syndrome. Therefore, it is essential that supplementary endovenous procedures have to be performed in case of persistent obstructive lesions following catheter-directed thrombolysis. Insertion of a

APA, Harvard, Vancouver, ISO, and other styles

43

Schmidt, Jens-Ove, Johnny Kent Christensen, and Kim Christian Houlind. "Calcified in-stent restenosis in a venous stent." Journal of Vascular Surgery Cases 1, no. 4 (2015): 261–63. http://dx.doi.org/10.1016/j.jvsc.2015.07.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Jang, Joo Yeon, Ung Bae Jeon, Jung Hwan Park, et al. "Efficacy and patency of primary stenting for hepatic venous outflow obstruction after living donor liver transplantation." Acta Radiologica 58, no. 1 (2016): 34–40. http://dx.doi.org/10.1177/0284185116637247.

Full text

Abstract:

Background Hepatic venous outflow is important for graft survival in living donor liver transplantation (LDLT). If hepatic venous outflow obstruction occurs, hepatic vein stenting is considered to restore the patency. Purpose To retrospectively evaluate the efficacy and patency of primary hepatic vein stenting for hepatic venous outflow obstruction (HVOO) after LDLT. Material and Methods Percutaneous interventions, including hepatic vein stent placement with or without balloon angioplasty, were performed in 21 patients who had undergone LDLT and had HVOO confirmed through hepatic venography or

APA, Harvard, Vancouver, ISO, and other styles

45

Takada, Shigeki, Fumiaki Isaka, Takuya Nakakuki, Yuto Mitsuno, and Takaaki Kaneko. "Torcular dural arteriovenous fistula treated via stent placement and angioplasty in the affected straight and transverse sinuses: case report." Journal of Neurosurgery 122, no. 5 (2015): 1208–13. http://dx.doi.org/10.3171/2014.12.jns141374.

Full text

Abstract:

The successful obliteration of torcular dural arteriovenous fistula (DAVF) with a diffuse shunt in the affected sinus may require complex treatment strategies. Therapeutic goals include the preservation of normal venous drainage and complete obliteration of shunt flow. The authors report the case of a torcular DAVF. The treatment of this type of AVF may require a combined approach with transarterial and transvenous embolization, open surgery, or radiosurgery and is associated with many problems. Stent placement and angioplasty in the affected sinus result in compression of the fistulous dural

APA, Harvard, Vancouver, ISO, and other styles

46

Buell, Thomas J., Robert M. Starke, Dale Ding, et al. "Venous Sinus Stenting using Transcranial Access for the Treatment of Idiopathic Intracranial Hypertension in a Pediatric Patient." Journal of Neurosciences in Rural Practice 08, no. 04 (2017): 672–75. http://dx.doi.org/10.4103/jnrp.jnrp_135_17.

Full text

Abstract:

ABSTRACTA 4-year-old male with headaches, papilledema, intracranial hypertension, and bilateral transverse sinus (TS) stenosis underwent attempted percutaneous placement of a right TS stent. Stent deployment was not technically feasible due to the stiffness of the stent and tortuosity of the patient's jugular bulb. Therefore, the patient underwent hybrid endovascular stenting of the right TS using neuronavigation and direct access of the TS following a single burr hole craniectomy. Two Express 8 mm × 17 mm balloon-mounted stents were deployed into the right TS, which resulted in obliteration o

APA, Harvard, Vancouver, ISO, and other styles

47

van Vuuren, Timme MAJ, Ralph LM Kurstjens, Mark AF de Wolf, Jorinde HH van Laanen, Cees HA Wittens, and Rick de Graaf. "Stent extension into a single inflow vessel is a valuable option after endophlebectomy." Phlebology: The Journal of Venous Disease 33, no. 9 (2017): 610–17. http://dx.doi.org/10.1177/0268355517739766.

Full text

Abstract:

Background Venous stenting with an endophlebectomy and arteriovenous fistula can be performed in patients with extensive post-thrombotic changes. However, these hybrid procedures can induce restenosis, sometimes requiring stent extension, into a single inflow vessel. This study investigates the effectiveness of stenting into a single inflow vessel. Methods All evaluated patients had temporary balloon occlusion of the arteriovenous fistula to evaluate venous flow into the stents. When stent inflow was deemed insufficient, AVF closure was postponed and additional stenting was performed. Patency

APA, Harvard, Vancouver, ISO, and other styles

48

Chen, Bin, Run Lin, Haitao Dai, et al. "One-year outcomes and predictive factors for primary patency after stent placement for treatment of central venous occlusive disease in hemodialysis patients." Therapeutic Advances in Chronic Disease 13 (January 2022): 204062232110630. http://dx.doi.org/10.1177/20406223211063039.

Full text

Abstract:

Objective: The study purpose was to determine the outcomes and factors predictive of primary stent patency for the treatment of central venous occlusive disease (CVOD) in hemodialysis patients. Methods: Data of 71 patients with CVOD treated with stent placement from January 2012 to December 2017 were analyzed. Univariate and multivariate analysis was performed to determine factors associated with stent patency. Adverse events related to stent placement were also examined. Results: The median primary patency duration of the 71 patients was 16 ± 2.2 months. The cumulative 3-, 6-, 9-, and 12- mon

APA, Harvard, Vancouver, ISO, and other styles

49

Ribichini, Flavio, Francesco Pugno, Valeria Ferrero, et al. "Long-term histological and immunohistochemical findings in human venous aorto-coronary bypass grafts." Clinical Science 114, no. 3 (2008): 211–20. http://dx.doi.org/10.1042/cs20070243.

Full text

Abstract:

The aim of the present study was to analyse the long-term histology and immunohistochemistry of the plaque composition and cellular infiltration of SVGs (saphenous vein grafts) containing metallic stents. Percutaneous interventions in SVGs have a worse long-term clinical outcome compared with stenting of coronary arteries. Whether the pathological features of old degenerated SVGs condition the efficacy of drug-eluting stents is also unknown. Histology and immunohistochemistry of seven SVGs in the coronary circulation containing 12 metallic stents implanted 5 to 61 months before retrieval were

APA, Harvard, Vancouver, ISO, and other styles

50

Choi, Sun-Ju, Young Woo Do, Tak-Hyuk Oh, et al. "Central venous catheterization–induced right brachiocephalic vein pseudoaneurysm: Successfully treated with stent-assisted coiling." Journal of Vascular Access 19, no. 3 (2018): 319–23. http://dx.doi.org/10.1177/1129729817746581.

Full text

Abstract:

Introduction: Central venous catheterization–induced central vein pseudoaneurysm is rare. Several treatment options have been recommended. We describe a case of central venous catheterization–induced right brachiocephalic vein pseudoaneurysm successfully treated with an uncovered self-expandable stent-assisted coil embolization and discuss the imaging findings, treatment strategy, and review of literature associated with thoracic venous pseudoaneurysm. Case report: A 77-year-old woman was referred to our trauma center to undergo treatment for central venous catheterization-induced central vein

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!